Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Response
100%
Ewing Sarcoma
100%
Death Receptor 5
100%
Caspase-8
100%
Agonist Antibody
100%
Response to Death
100%
Conatumumab
57%
Death Receptor
28%
Sarcoma Cells
28%
Preclinical Evaluation
28%
Prognostic Biomarker
28%
Tumor
14%
Recurrent Disease
14%
Disease-associated
14%
Tumor Growth
14%
Poor Prognosis
14%
Response to Chemotherapy
14%
Apoptosis
14%
Therapeutic Agents
14%
Mouse Tumor Model
14%
Immunoblot
14%
Dose-response
14%
Catalytic Activity
14%
Targeted Agents
14%
Gene Transfer
14%
Statistical Comparison
14%
Kaplan-Meier Estimator
14%
Receptor Targets
14%
Cell Viability Assay
14%
Fast Activation
14%
Model Comparison
14%
Patient-derived Xenograft
14%
Drug Dosage
14%
Medicine and Dentistry
Ewing Sarcoma
100%
Death Receptor 5
100%
Caspase 8
100%
Tumor
100%
Conatumumab
57%
In Vitro
28%
Biological Marker
28%
Death Receptor
28%
Ewing Sarcoma Cell Line
28%
Cell Line
14%
Recurrent Disease
14%
Tumor Progression
14%
Kaplan Meier Method
14%
Programmed Cell Death
14%
Tumor Model
14%
Xenograft
14%
Dose Response
14%
Therapeutic Agent
14%
Immunoblotting
14%
Gene Transfer
14%
Cell Viability Assay
14%
Chemotherapy
14%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Caspase 8
100%
Ewing Sarcoma
100%
Tumor Progression
14%
Cell Viability
14%
Dose Response
14%
Immunoblotting
14%
Enzymatic Activity
14%
Programmed Cell Death
14%